Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2000017	重组人血管内皮抑制素注射液	Recombinant Human Endostatin	Injection	Biological Products	Supplementary Application	2020-01-23	山东先声生物制药有限公司	Shandong Simcere Bio-Pharmaceutical Co Ltd	In Review	2020-01-22	view
CXSL2100008	重组人血管内皮抑制素注射液	Recombinant Human Endostatin	Injection	Biological Products(2.2)	New Drug Application	2021-01-09	山东先声生物制药有限公司	Shandong Simcere Bio-Pharmaceutical Co Ltd	In Review	2021-01-08	view